GLP-1 injectable medications, such as semaglutide (Wegovy) and tirzepatide (Zepbound), are showing powerful results in weight management
However, slowed stomach emptying (delayed gastric transit) can produce nausea, vomiting, and constipation in the general population, side effects that may interact unpredictably with Crohn's disease pathophysiology
Moreover, liraglutide therapy was well tolerated with a low risk of hypoglycemia, and the beneficial effects were maintained for at least 12 months [14]
its effects on the body can be influenced significantly by other dietary elements
doi: 10.1016/j.freeradbiomed.2021.09.001 78
Contact us to schedule a consultation and embark on your journey towards a healthier, happier you